Cardiology
Articles tagged with Cardiology
UMCG studies show: Centuries-old medicine benefits heart failure patients
Association of childhood outdoor play with adult sedentary behavior and physical activity in patients with congenital heart disease
Concordia-designed CPR simulator for space use tracks the differences of blood flow in reduced gravity
A Concordia-designed simulator models hemodynamics in reduced gravity environments, revealing key differences in blood flow and pressure patterns. The system successfully reproduced effective CPR on Earth and generated consistent blood flow under both normal and hypogravity conditions.
Swimming beats running for strengthening the heart, study finds
A recent study published in Scientific Reports found that swimming is more effective than running in promoting healthy heart growth and improving heart muscle strength. Swimming promoted greater modulation of microRNAs, which control various heart adaptations, compared to running training.
Study examines clinical outcomes based on antiplatelet bridging dosing patterns post-PCI
A multi-center retrospective cohort study examined how cangrelor is used in real-world clinical practice around the time of surgery following PCI. The study found that varying dosing patterns can affect outcomes, with higher infusion rates associated with increased bleeding events and lower infusion rates linked to higher major adverse...
Novel blood return system cuts blood loss by 97% in pulmonary embolism procedure
A novel blood return system has been shown to significantly reduce blood loss during pulmonary embolism procedures, with a median reduction of 97%. The study found that the system improved procedural efficiency and maintained hemodynamic efficacy without added therapies or major complications.
Lipoprotein(a) linked to elevated cardiovascular risk despite standard treatment
Researchers found that elevated Lipoprotein(a) levels are associated with a higher risk of major adverse cardiovascular events, including stroke and death. Patients with high Lp(a) levels should work closely with their healthcare provider to aggressively lower LDL cholesterol and manage other cardiovascular risk factors.
REACH trial found smart algorithm using finger cuff technology detected moderate-to-severe as cases in African American patients with excellent performance
A novel detection algorithm using finger cuff technology detected moderate-to-severe aortic stenosis with a sensitivity of 90.5% and 100% in African American patients, showing excellent performance for screening purposes.
Clopidogrel seems to outperform aspirin for secondary chronic maintenance therapy
New findings suggest that clopidogrel monotherapy is associated with a lower risk of net adverse clinical events compared to aspirin monotherapy, even in patients at high risk of bleeding. This benefit is more pronounced in patients with high bleeding risk and complex procedures.
COVID-19 and severe heart attack increase mortality by 25% after one year, more than double pre-pandemic rates
A new study found that COVID-19 significantly worsens cardiovascular outcomes, leading to higher one-year mortality rates in patients with severe heart attacks. Patients who survived a heart attack and experienced COVID-19 had a 25% higher one-year mortality rate compared to those without COVID-19.
Radial arterial access demonstrates procedural safety for the treatment of peripheral artery disease
The CARPOOL study demonstrates radial-to-peripheral access achieves comparable procedural success rates to traditional common femoral artery access for lower extremity peripheral artery disease revascularization. However, the R2P group had higher major adverse limb events at six months due to target vessel revascularization.
JSCAI simultaneously publishes seven original research studies at SCAI 2026 scientific sessions
Seven original research studies on cardiometabolic therapies, structural heart disease, peripheral intervention, and shock care are published simultaneously by JSCAI at SCAI 2026. These findings highlight the intersection of cardiometabolic management and structural heart care, with implications for patient outcomes.
Electronic provider notifications increase lifesaving valve replacement by more than 50% in elderly patients with severe symptomatic aortic stenosis
A new study found that electronic provider notifications significantly increased aortic valve replacement rates and improved survival among older patients with severe symptomatic aortic stenosis. The DETECT-AS trial showed that clinicians who received automated email alerts with abnormal heart ultrasound results detected AS were more l...
Minimally invasive valve repair safe and effective for patients with mitral annular calcification
The MitraClip procedure has been shown to be safe and effective for patients with mitral annular calcification, improving symptoms and quality of life. Despite higher mortality rates, patients with MAC experienced significant reductions in mitral regurgitation and improvements in quality of life, indicating a promising treatment option.
Surgical innovation could provide thousands of children with new hearts valves that grow with them
Partial heart transplantation replaces only defective valves and related structures, eliminating need for repeat replacements. This procedure can provide thousands of additional valve transplants annually, benefiting young patients worldwide.
Over the past decade, congestive heart failure and heart rhythm-related cardiogenic shock deaths increased by over 10%
Deaths from non-ischemic CS have risen sharply in the US, while ischemic CS deaths declined between 1999-2020. Researchers warn of a growing public health challenge that requires policy initiatives and targeted trials.
New STEMI-DTU data provide deeper insight into patient outcomes
The STEMI-DTU trial analyzed secondary endpoints, finding that major bleeding and vascular complications were associated with increased mortality in the control group. The study provided insight into the importance of technique and bleeding complications in heart attack treatments.
Emerging minimally invasive procedure reduces circulation concerns by 50% in patients with no-option chronic limb-threatening ischemia
Transcatheter arterialization of the deep veins (TADV) significantly improves quality of life in patients with severe CLTI, reducing concerns about poor circulation and daily activities. Six months post-procedure, patients showed a 50% reduction in circulation concerns, improved sleep patterns, and reduced foot wound symptoms.
‘Leave-nothing-behind’ strategy works as well as drug-eluting stent for heart attack and chest pain patients
A new sub-study suggests that using a sirolimus-eluting balloon can reduce the number of stents needed, making it a safe and effective way to treat certain heart attacks or unstable chest pain. At one year, the rates of target vessel failure and cardiac death were low and similar between the two groups.
TAVR Google searches surge over 300% in past decade, corresponding with expanded adoption of transcatheter approaches
Researchers found a significant increase in TAVR search volume and a decline in SAVR searches over the past decade, reflecting a shift towards minimally invasive therapies. The study also highlighted disparities in awareness across rural and low-volume treatment areas.
Novel minimally invasive treatment demonstrates significant sustained improvement for heart valve patients with limited options
A new transcatheter mitral valve replacement (TMVR) procedure has shown significant benefits for patients with severe mitral regurgitation, reducing symptoms and improving quality of life. The study found that the treatment sustained clinical improvements over one year, with no major complications.
Among women with heart attack-related cardiogenic shock, goals of care twice as likely to drive management decisions compared to men
A registry analysis found that while men and women with acute myocardial infarction-related cardiogenic shock differ in treatment options, clinical decisions are driven by objective markers of illness severity rather than sex. The study suggests significant differences in how treatment options are discussed with patients and caregivers.
GLP-1–based drug tirzepatide reduces heart risk in high-risk patients
Tirzepatide significantly reduces cardiovascular risk in high-risk patients, including those undergoing percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR). The study found tirzepatide consistently reduced major adverse cardiovascular events and mortality across multiple time points.
Minimally invasive percutaneous arterial bypass shows strong outcome regardless of distal vessel flow
Researchers found that patients with single-vessel runoff maintained excellent patency through three years, and could safely benefit from minimally invasive treatment. The study results showed no significant difference in outcomes for patients with one or more vessels running blood to the lower leg.
Shock initiative demonstrates over 70% survival in patients with cardiogenic shock, with improved outcomes in stage E shock at centers with escalation capabilities
The CERAMICS registry found that most patients survived hospital discharge, with 71% overall survival and 60% of those in the most severe stage E shock. Early use of a small heart pump improves outcomes in patients experiencing cardiogenic shock after a heart attack and stenting procedure.
Midlife fitness linked to longer, healthier lives
A study found that higher midlife cardiorespiratory fitness is strongly associated with later onset of chronic disease, lower overall disease burden, and longer life expectancy. Adults with higher fitness levels developed fewer chronic diseases and spent more years free from serious illness.
Reimagining heart transplant allocation worldwide
A new global allocation system is being proposed to address inequities in organ allocation for heart transplants. The proposal aims to reduce disparities and ensure no viable donor heart goes unused globally.
American College of Cardiology recognizes 20 FACCs during ACC Asia 2026
The American College of Cardiology recognized 20 individuals from eight countries for earning the Fellow of ACC (FACC) designation. The award reflects a strong commitment to improving patient care and advancing cardiovascular research.
New material makes heart monitoring tech more comfortable
Researchers created a new polymer electrode that conforms to the skin, is comfortable, and can pick up ECG signals without gel or adhesives. The technology performed comparably to existing sensors in proof-of-concept testing, showcasing its potential for practical and cost-effective health monitoring applications.
Korean women with CVD face gaps in risk factor control
A study analyzing Korean National Health and Nutrition Examination Survey data reveals higher awareness and treatment of major risk factors among Korean women with CVD, but lower control rates. Sex differences were observed in most management indicators, with men having more risk factors on average.
Images and risk communication boost motivation for better heart health
A study from Umeå University found that visualizing ultrasound images of atherosclerosis, combined with a motivational dialogue, increases motivation to improve lifestyle habits and take preventive medication. This results in lower estimated risk of cardiovascular disease and better development of risk factors over time.
SCAI reappoints JSCAI founding Editor-in-Chief Alexandra J. Lansky, MD, MSCAI, for second term
Alexandra J. Lansky, MD, MSCAI, has been reappointed to a second five-year term as Editor-in-Chief of JSCAI, the official peer-reviewed journal of SCAI. The journal has rapidly expanded its global reach and established itself as a trusted source for original research, clinical guidance, and educational content in interventional cardiol...
University Hospitals now offering new therapy for refractory ventricular tachycardia
Researchers at University Hospitals Cleveland Medical Center have introduced a new, non-invasive treatment option for patients with refractory ventricular tachycardia, a life-threatening heart condition. The therapy uses precision-targeted radiation to neutralize damaged heart tissue and is offered at select centers worldwide.
ACC Asia 2026 showcases cutting-edge cardiovascular care for the Asia-Pacific region
The conference brings together leading experts to examine emerging trends and evidence-based approaches to preventing and managing heart disease. Cardiometabolic disease accounts for a significant burden in the Asia-Pacific region, with rapid urbanization, digitalization, and uneven health-system capacity contributing to this issue.
Leading cardiovascular organizations unite for joint scientific sessions, highlighting the latest advancements in cardiology internationally
The Society for Cardiovascular Angiography & Interventions and Canadian Association of Interventional Cardiology will host a joint conference featuring the latest clinical data, procedural guidance, and advanced expertise. The event aims to empower clinicians with rigorous data, practical education, and leadership development.
EuroPCR 2026 - The world-leading course in interventional cardiovascular medicine: Forming generations of the interventional community through excellence in education and innovation
EuroPCR 2026 will feature 4 days of quality content, case-based learning sessions, and interactive formats. The course is designed for all levels of experience, covering topics in interventional cardiology, nursing, and research. EuroPCR aims to advance the quality of interventional practice and provide a transformative experience.
Small-volume hypertonic saline plus furosemide linked to lower inflammatory and remodeling markers in acute heart failure
Treatment with i.v. furosemide plus HSS significantly decreased serum levels of inflammatory biomarkers IL-6, sST2, hsTnT, galectin-3, and NT-proBNP. The study found that this combination therapy modulated some miRNA expression and was associated with reduced miR181b expression compared to furosemide alone.
Transforming high-quality care at East Campus Medical Center
East Campus Medical Center has doubled its average daily census since 2024, with over 4,000 patients transferring to the hospital from other UC San Diego Health locations. The hospital now offers expanded services in cardiology, gastroenterology, and more, with a focus on continuity and relationship-based medicine.
GLP-1 receptor agonists and noncardiometabolic outcomes
A meta-analysis of GLP-1 receptor agonist studies found potential safety signals for gastrointestinal side effects, while some evidence suggested a link to reduced respiratory disease risk. Further research is needed to confirm the latter association.
Dr. Roxana Mehran is new American College of Cardiology president
Dr. Roxana Mehran begins a one-year term as president of the American College of Cardiology, leading a global organization with over 60,000 members. She aims to strengthen partnerships and foster growth, opportunity, and impact.
New brain–heart guideline takes holistic approach to chronic disease management
The new brain–heart clinical practice guideline provides a holistic approach to managing chronic diseases by integrating neurologic and mental health evidence with cardiovascular guidance. The guideline aims to improve the management of patients with concurrent brain and heart diseases, which often co-occur and share similar risk factors.
Dr. Renuka Jain is new chair of ACC Board of Governors
Dr. Renuka Jain has been appointed as the new chair of the American College of Cardiology Board of Governors, a role that will empower governors and strengthen Chapter foundations. Her priorities include setting up governors for success, strengthening advocacy at state and national levels, and creating leadership pipelines.
Long-term durability of acoramidis efficacy in transthyretin amyloid cardiomyopathy
Early and continuous acoramidis treatment resulted in sustained incremental reductions in all-cause mortality, cardiovascular-related mortality, and first cardiovascular hospitalization. The findings support the importance of early and continuous long-term treatment with acoramidis in transthyretin amyloid cardiomyopathy.
Mount Sinai’s Roxana Mehran, MD, named President of the American College of Cardiology
Dr. Roxana Mehran was appointed President of the American College of Cardiology, focusing on innovation, equity, and global collaboration to advance cardiovascular care. She aims to improve heart health for all through partnerships with major organizations.
Novel technique for measuring blood flow restriction shows promise
A novel minimally invasive method for determining fatty deposits in coronary arteries restricting blood flow has produced similar outcomes to conventional FFR, according to a European randomized trial. The technique, called vessel FFR, uses computer analysis of three-dimensional images to calculate blood-flow restriction severity.
Sotatercept shows promise for an uncommon type of pulmonary hypertension linked to heart failure with preserved ejection fraction
A Phase 2 trial found significant benefits for patients with poor prognosis and limited options, including improved six-minute walking distance and right heart function, and a lower rate of clinical worsening events. Sotatercept reduced pulmonary vascular resistance and showed a favorable safety profile.
Minimally invasive valve repair reduces heart failure hospitalizations in patients with severe tricuspid regurgitation
A minimally invasive procedure using a clip to repair the valve significantly reduced heart failure hospitalizations by 40% in patients with severe tricuspid regurgitation. The study, presented at the American College of Cardiology's Annual Scientific Session, showed improved long-term outcomes without crossover between treatment groups.
Mitral valve-in-valve procedure associated with lower risk of death, disabling strokes
A minimally invasive procedure to insert a new valve showed lower one-year event rates for death or disabling stroke compared to traditional repeat mitral valve replacement surgery. The study found that transcatheter mitral valve-in-valve (mVIV) reduced in-hospital deaths, acute kidney injury, and life-threatening bleeding complications.
Extended low-dose apixaban and superficial vein thrombosis
Extended low-dose apixaban effectively reduced symptomatic superficial vein thrombosis (SuVT) risk. Patients with enduring risk factors for SuVT benefited from this anticoagulation strategy.
Novel method to assess coronary flow similar to gold standard
A novel software-based method combines AI to evaluate plaque restriction in coronary arteries, producing similar clinical outcomes as the gold standard wire-based procedure. The FFRangio technique eliminated additional procedural steps and was faster to perform.
Dual imaging identifies cause of heart attack in patients without blocked arteries
A new study led by NYU Langone Health finds that combining advanced imaging tests can identify the underlying cause of heart attacks in most patients without blocked arteries. The research used coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to reveal a likely cause in 79 percent of patients.
Mavacamten improves obstruction in adolescents with HCM
A small study found mavacamten significantly improved left ventricular outflow tract gradient and symptoms in adolescents with obstructive HCM. The treatment may also reverse some heart damage and favorably remodel the heart, suggesting potential benefits for children diagnosed with the disease.
Older, high-risk patients can safely defer PCI until after TAVR
The PRO-TAVI study found that older, high-risk patients can safely defer percutaneous coronary intervention (PCI) until after transcatheter aortic valve replacement (TAVR), with comparable outcomes between the two groups. Omitting PCI before TAVR did not increase the risk of death, heart attack, stroke, or moderate to severe bleeding.
Pregnancy-associated spontaneous coronary artery dissection
The study found that women with pregnancy-associated spontaneous coronary artery dissection (P-SCAD) have a higher risk of cardiovascular events, including dissections and aneurysms. Women with P-SCAD also experienced less recovery in left ventricular ejection fraction compared to those without P-SCAD.
Study finds no significant benefit of spironolactone in HFpEF or HFmrEF
The SPIRIT-HF trial found that spironolactone did not improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF) and mildly reduced ejection fraction (HFmrEF). The study also raised safety concerns about the use of spironolactone in older patients with heart failure.
Angioplasty reduces chest pain, boosts QoL in chronic total occlusion
The ORBITA-CTO trial found that angioplasty reduced angina episodes and improved quality-of-life scores in patients with chronic total occlusion. Patients who received CTO angioplasty were four times more likely to experience improved angina scores, with a significant reduction in angina-free days.
No benefit for left-ventricular unloading in patients with severe LV dysfunction undergoing complex PCI
Patients who received temporary heart pump had almost double the risk of dying from a cardiovascular event compared to those receiving standard care. The study found no evidence that the device protected the heart during the angioplasty procedure.
Serum neurofilament light chain and cardiovascular outcomes in patients with atrial fibrillation
Patients with atrial fibrillation have a higher risk of adverse cardiovascular events, including stroke, heart attack, and cardiac arrest. Serum neurofilament light chain levels can serve as a biomarker for cardiovascular risk in these patients.
Biomarker, functional status, and quality-of-life trajectories before modes of death in heart failure
A post hoc analysis of the Finerenone Trial reveals that sudden death in heart failure was often preceded by modest worsening of symptoms and declining quality of life. The study suggests limited specificity for sudden death among other modes of death, implying a complex trajectory before modes of death.